UK considers options after spike in daily coronavirus infections

The number of Covid-19 cases in the country is now at its highest since March 25

Coronavirus UK
UK. Photo: Bloomberg
Press Trust of India London
4 min read Last Updated : Jun 05 2021 | 5:08 PM IST

The UK government on Saturday said it is considering options around a planned end to lockdown on June 21 after the country recorded the highest number of daily COVID-19 cases in just over two months.

The UK recorded a further 6,238 coronavirus cases on Friday as England's R number, or the rate of infection, continues to rise and the latest government numbers also show another 11 COVID-19 related deaths.

"Of course officials are drawing up other options but we are still expecting to be in a place to go ahead on June 21," a UK government figure told Sky News'.

Options under discussion are said to include retaining the wearing of face masks in certain settings and continuing the work from home advice, even as the hospitality sector opens up. However, the government maintains that there is "nothing in the data" to suggest ending lockdown should be delayed.

The number of COVID-19 cases in the country is now at its highest since March 25, when 6,397 were recorded, and the spike is largely down to the Delta variant or the highly transmissible B1.617.2 variant of concern (VOC) first detected in India.

UK Health Secretary Matt Hancock said that a rise of cases was to be expected as the country came out of lockdown.

"We always expected cases to rise as the country was opened up, the critical thing is the impact on the number of people who end up in hospital for any given number of cases, said Hancock.

"That link has been broken by the vaccine, but it hasn't been completely severed yet. That's one of the things that we're watching very carefully, and it's too early to say what the decision will be ahead of June 21, but we'll make sure people know in good time," he said.

The National Health Service (NHS) said it has seen a huge jump in the number of people coming forward for a COVID jab since launching its plan to tackle vaccine hesitancy. There has been an increase of more than a fifth among adults under 45 who would definitely get their vaccine according to a new study, which surveyed 16,610 people from a nationally representative sample.

According to the findings, 63 per cent would definitely get the jab, with a further 21 per cent likely to accept.

Anyone aged 30 and above is now eligible for a vaccine and the NHS said more than half of people in their thirties have already been jabbed.

Tackling vaccine hesitancy has been at the heart of the NHS vaccination programme, the biggest in NHS history, which has so far delivered more than 55 million doses across England, said Dr Nikki Kanani, NHS national medical director for primary care.

The vaccine is proven to be safe and effective, and it's vital that everyone gets both first and second doses in order to get full protection against coronavirus so when you are invited, please do not hesitate to book in and do what you can to protect yourself, your families and your communities from COVID, she said.

Meanwhile, according to some reports, the government is considering accelerating the vaccine rollout even further with over-40s set to get their second jab within eight weeks of the first rather than 12 as was the case with over-50s. Everyone aged 25 and over is also expected to be offered their first doses from next week.

On Friday, scientists from the Francis Crick Institute called for the speeding up of second doses after a study of the Pfizer/BioNTech vaccine found that it produced lower antibody levels in those with the Delta variant of COVID-19.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: Jun 05 2021 | 5:01 PM IST

Next Story